Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2022 Dec 22;16(1):10.
doi: 10.3390/ph16010010.

Automatic Production of [18F]F-DOPA Using the Raytest SynChrom R&D Module

Affiliations

Automatic Production of [18F]F-DOPA Using the Raytest SynChrom R&D Module

Paweł Waśniowski et al. Pharmaceuticals (Basel). .

Abstract

[18F]F-DOPA is widely used in PET diagnostics. Diseases diagnosed with this tracer are schizophrenia, Parkinson's disease, gliomas, neuroendocrine tumors, pheochromocytomas, and pancreatic adenocarcinoma. It should be noted that the [18F]F-DOPA tracer has been known for over 30 years. However, the methods of radiosynthesis applied in the past did not allow its clinical use due to low efficiency and purity. Currently, in the market, one encounters different types of radiosynthesis using the fluorine 18F isotope and variants of the same method. The synthesis and its modifications were carried out using a Raytest Synchrom R&D module. The synthesis consists of the following steps: (a) binding of the fluoride anion 18F- on an anion exchange column; (b) elution with TBAHCO3-; (c) nucleophilic fluorination to the ABX 1336 precursor; (d) purification of the intermediate product on the C18ec column; (e) Baeyer-Villiger oxidation; (f) hydrolysis; and (gfinal purification of the crude product on a semipreparative column. The nucleophilic synthesis of [18F]F-DOPA was successfully performed in 120 min, using the ABX 1336 precursor on the Raytest SynChrom R&D module, with a radiochemical yield (RCY) of 15%, radiochemical purity (RCP) ≥ 97%, and enantiomeric purity (ee) ≥ 96%.

Keywords: Raytest SynChrom R&D; [18F]F-DOPA; radiosynthesis.

PubMed Disclaimer

Conflict of interest statement

The authors declare no conflict of interest.

Figures

Figure 1
Figure 1
Uncleaned (a) reactor and (b) magnetic stirrer after the automatic cleaning procedure.
Figure 2
Figure 2
Modifications of the Raytest SynChrom R&D synthesis module.
Figure 3
Figure 3
Configuration of the Raytest SynChrom R&D module for [18F]F-DOPA synthesis.
Figure 4
Figure 4
Reaction with too low an amount of mCPBA.
Figure 5
Figure 5
Reaction with too high an amount of mCPBA.
Figure 6
Figure 6
Reaction with the correct amount of mCPBA.
Figure 7
Figure 7
Schematic depiction of reaction conditions for [18F]F-DOPA synthesis using the ABX 1336 precursor.

Similar articles

Cited by

References

    1. Garnett E.S., Firnau G., Nahmias C. Dopamine visualized in the basal ganglia of living man. Nature. 1983;305:137–138. doi: 10.1038/305137a0. - DOI - PubMed
    1. Fischman A.J. Role of [18F]-dopa-PET imaging in assessing movement disorders. Radiol. Clin. N. Am. 2005;43:93–106. doi: 10.1016/j.rcl.2004.08.002. - DOI - PubMed
    1. Darcourt J., Schiazza A., Sapin N., Dufour M., Ouvrier M.J., Benisvy D., Fontana X., Koulibaly P.M. 18F-FDOPA PET for the diagnosis of parkinsonian syndromes. Q. J. Nucl. Med. Mol. Imaging. 2014;58:355–365. - PubMed
    1. Groves A.M., Win T., Haim S.B., Ell P.J. Non-[18F]FDG PET in clinical oncology. Lancet Oncol. 2007;8:822–830. doi: 10.1016/S1470-2045(07)70274-7. - DOI - PubMed
    1. Seibyl J.P., Chen W., Silverman D.H. 3,4-Dihydroxy-6-[18F]fluoro-L-phenylalanine positron emission tomography in patients with central motor disorders and in evaluation of brain and other tumors. Semin. Nucl. Med. 2007;37:440–450. doi: 10.1053/j.semnuclmed.2007.08.002. - DOI - PubMed

LinkOut - more resources